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Down-regulation of urea transporters in the renal inner me- treated rats also have a reduction in vasopressin-stimu-
dulla of lithium-fed rats. lated cAMP production and vasopressin-stimulated os-
Background. Lithium is commonly used to treat bipolar psy- motic water permeability [7–13]. Thus, a defect in vaso-chiatric disorders but can cause reduced urine concentrating
pressin-regulated water reabsorption contributes to theability.
polyuria and urine concentrating defect observed in lith-Methods. To test whether lithium alters UT-A1 or UT-B urea
transporter protein abundance or UT-A1 phosphorylation, rats ium-treated rats.
were fed a standard diet supplemented with LiCl for 10 or 25 Chronic lithium administration also results in a marked
days, and then compared to pair-fed control rats. To investigate reduction in inner medullary interstitial osmolality due toanother potential mechanism for decreased urea transport, in-
lower interstitial urea and NaCl concentrations [11]. Knep-ner medullary collecting duct (IMCD) suspensions from lith-
per and colleagues examined the major sodium transportium-fed or control rats were incubated with 32P-orthophosphate
to measure the phosphorylation of UT-A1. proteins in the medulla of lithium-treated rats but found
Results. In lithium-fed rats (25 days), UT-A1 abundance no consistent decrease in their abundance that could
was reduced to 50% of control rats in IM tip and to 25% in
explain the reduced level of interstitial NaCl [14]. There-IM base, and UT-B abundance was reduced to 40% in IM
fore, our first objective was to determine whether thebase. Aquaporin-2 (AQP2) protein abundance was reduced
in both IM regions. Vasopressin (100 pmol/L) increased UT- UT-A1 or UT-B urea transporter proteins [reviewed in
A1 phosphorylation in IMCD suspensions from control but 15, 16] were reduced in the inner medulla of lithium-
not from lithium-fed rats; a higher vasopressin concentration treated rats.(100 nmol/L) increased UT-A1 phosphorylation in control and
In addition to increasing water permeability, vasopres-lithium-fed rats.
sin increases urea permeability in perfused rat terminalConclusions. Decreases in UT-A1, UT-B, and AQP2 protein
abundance, and/or vasopressin-stimulated phosphorylation of inner medullary collecting ducts (IMCDs) [17] through
UT-A1, can contribute to the reduced urine concentrating abil- a cyclic–3,5-adenosine monophosphate (cAMP)-depen-
ity that occurs in lithium-treated rats.
dent pathway [18]. We recently showed that vasopres-
sin, acting through protein kinase A, increases the phos-
phorylation of UT-A1 protein in IMCD suspensions [19].
Lithium is widely used to treat patients with manic– Therefore, our second objective was to determine whe-
depressive (bipolar) disorders. The most frequent side ther vasopressin’s stimulation of UT-A1 phosphoryla-
effect of lithium is nephrogenic diabetes insipidus and tion was perturbed in lithium-treated rats.
an inability to concentrate urine, with an estimated prev-
alence of 20–70% [1–4]. The mechanisms by which lith-
ium causes nephrogenic diabetes insipidus are not en- METHODS
tirely understood. Lithium-treated rats have a marked Animal models
reduction in aquaporin-2 (AQP2) protein [1, 5] despite
Male Sprague-Dawley rats (National Cancer Institute,having an elevated plasma vasopressin level [6]. Lithium-
Frederick, MD, USA) were fed a standard diet supple-
mented with LiCl (60 mmol/kg) for 10 or 25 days [5, 6,
11, 14]. This dosage and time course were chosen sinceKey words: nephrogenic diabetes insipidus, vasopressin, cAMP, con-
centrating mechanism, phosphorylation, aquaporin. they result in serum lithium levels at the lower end of the
therapeutic range (in humans) while minimizing weightReceived for publication September 4, 2001
loss in the rats [5, 6, 11, 14]. Rats were given free accessand in revised form October 19, 2001
Accepted for publication October 22, 2001 to water and salt wheels (Pet Smart, Atlanta, GA, USA)
were placed in each cage [5, 6, 11, 14]. Control rats were 2002 by the International Society of Nephrology
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Table 1. In vivo parameters following 25 days of lithium administrationfed the same food, except that no LiCl was added, and
given free access to water and salt wheels. The control Parameter Control rats Lithium-treated rats
rats were pair-fed to the lithium-treated rats during the Initial body weight g 1859 1889
Final body weight g 28811 25813last 10 days of the study. All rats were placed in metabolic
Serum lithium mmol/L — 0.60.1acages for the last 10 days of the study to permit 24-hour
Urine lithium mmol/L — 112a
urine collections. On the morning of the 10th or 25th day, 24-hour urine volume mL 132 4515a
Urine osmolality mOsm/kg H2O 1886150 696275athe rats were anesthetized using intraperitoneal pento-
barbital (Nembutal; Abbott Laboratories, North Chicago, Data are mean  SE, N  9 rats/group.
a Significantly different from pair-fed control rats at P  0.05IL, USA), a blood sample was obtained, and the kidneys
and liver were removed. Serum and urine lithium con-
centrations were determined by atomic absorption spec-
trophotometry in a graphite furnace at 671 nm (HGA- 20 minutes. Finally, the IMCDs were washed free of en-
600; AAS-3110; Perkin-Elmer Corp., Norwalk, CT, USA). zymes by centrifuging three times with exchanges of PO4-
Kidneys were dissected into base and tip regions of free Dulbecco’s modified Eagle’s medium (DMEM).
the inner medulla as described [20]: the base is the 1/3 The IMCD suspensions were placed into 1 mL of PO4-
of the inner medulla closest to the inner-outer medullary free DMEM containing 0.1 mCi/mL 32P-orthophosphate
border and corresponds to the location of the initial and incubated in 5% CO2 and 95% O2 at 37C for three
IMCD (or IMCD1); the tip corresponds to the deepest hours [19, 25]. Vasopressin (100 pmol/L or 100 nmol/L)
2/3 of the inner medulla (or true papilla) and corresponds was added directly to the radiolabeling solution 15 min-
to the location of the terminal IMCD (or IMCD2 and 3). utes prior to the end of the three-hour incubation. Un-
Tissue samples were homogenized in isolation buffer incorporated 32P was removed from the tubule suspen-
[10 mmol/L triethanolamine, 250 mmol/L sucrose, 1 g/ sion by three successive washes with PO4-free DMEM.
mL leupeptin, 0.1 mg/mL phenylmethylsulfonyl fluoride Next, the IMCD suspensions were homogenized in radio-
(PMSF), pH 7.6, 0.025 to 0.1 g tissue per mL isolation immunoprecipitation assay (RIPA) buffer [10 mmol/L
buffer] [20–22]. Concentrated sodium dodecyl sulfate Tris, pH 7.4; 2.5 mmol/L ethylenediaminetetraacetic acid
(SDS) was added to achieve a final concentration of (EDTA); 50 mmol/L NaF; 1 mmol/L Na4P2O7 · 10H2O;
1%, before samples were sheared by passage through a 1% Triton X-100; 10% glycerol; 1% deoxycholate, 1
26-gauge needle. The mixture was centrifuged for 15 g/mL aprotinin, 0.18 mg/mL PMSF, 0.18 mg/mL ortho-
minutes at 14,000  g and protein was determined using vanadate], sheared with a 26-gauge needle, and centri-
the BioRad DC protein assay kit (BioRad, Richmond, fuged to remove insoluble particulates.
CA, USA). The samples were incubated overnight with a C-termi-
nal antibody to UT-A1 [20] at 4C with gentle mixing.
Western analysis Immune complexes were precipitated with Protein A aga-
Total soluble proteins were separated on 10% (for rose for two hours at 4C, then the pelleted beads washed
UT-A1 and UT-B proteins) or 15% (for AQP2 protein) seven times with RIPA buffer. The washes were counted
SDS-polyacrylamide gels, and then transferred to poly- to ensure the complete removal of unbound radiolabeled
vinylidene difluoride (PVDF) membranes. Membranes material. Laemmli SDS-polyacrylamide gel electropho-
were probed with our affinity-purified polyclonal anti- resis (SDS-PAGE) sample buffer was added directly to
body to the C-terminus of UT-A1 that also recognizes the pellets, the samples were boiled for one minute, and
UT-A2 and UT-A4 [20, 21], UT-B [23], or AQP2 (gener- the proteins were size-separated on 10% SDS-polyacryl-
ous gift of Dr. B.K. Kishore, University of Utah) [24]. amide gels [19, 25].
The immunoreactive proteins were visualized by en-
Statisticshanced chemiluminescence (ECL; Amersham, Arling-
ton Heights, IL, USA) and quantitated using an Imaging All data are presented as mean SE and N number
Densitometer GS670 and Molecular Analyst software of rats. The Student t test or Mann-Whitney U test was
(Bio-Rad Laboratories, Hercules, CA, USA). Results used to test for statistical significance. The criterion for
are expressed as arbitrary units/g protein loaded. statistical significance was P  0.05.
Phosphorylation of UT-A1
RESULTSFresh suspensions of rat IMCDs were prepared as de-
In vivo parametersscribed [19] by cutting the inner medulla into small pieces
and placing them in buffer containing 2 mg/mL collagen- Rats fed lithium for 25 days had a serum lithium level
ase and 0.65 mg/mL hyaluronidase. The tissue pieces of 0.6  0.1 mmol/L and significantly increased urine
were incubated for 30 minutes at 37C, and then DNase volume and decreased urine osmolality compared to con-
trol pair-fed rats (Table 1). As an additional control to(5 L of 1 mg/mL) was added and incubated for another
Klein et al: Urea transporter regulation in LiCl-fed rats 997
Fig. 1. Aquaporin-2 (AQP2) protein abun-
dance in kidney inner medullary (IM) tip (A)
and base (B) from control rats and rats fed
LiCl for 25 days. Bottom panels are represen-
tative Western blots showing AQP2 protein
bands in IM tip (A) and base (B) from control
(C) and LiCl-fed (Li) rats. Each lane repre-
sents a sample from a separate rat. Top panels
are a densitometric summary of the sum of
the 35-45 kD (glycosylated) and 29 kD (non-
glycosylated) AQP2 bands on the gels. AQP2
protein abundance was significantly reduced
in LiCl-fed rats in both the IM tip and base,
compared to control rats. Data are mean 
SE, N  4 rats/group; *P  0.05.
Fig. 2. UT-A1 urea transporter protein abun-
dance in kidney inner medullary (IM) tip from
control rats and rats fed LiCl for 25 days. (A)
Representative Western blot showing UT-A1
protein bands in IM tip from control (C) and
LiCl-fed (Li) rats. Each lane represents a sam-
ple from a separate rat. (B) Densitometric
summary of the sum of the 117 and 97 kD
bands on the gels. There was a significant de-
crease in the density of the 117 and 97 kD
bands in LiCl-fed rats compared to control
rats. Data are mean  SE, N  8 rats/group;
*P  0.05.
evaluate the efficacy of lithium administration, we mea- UT-B protein abundance
sured AQP2 protein and found that it was significantly In the medulla, UT-B was a glycosylated protein that
reduced in both the inner medullary tip and base of runs as a smear between 40–50 kD on Western blot [23].
lithium-treated rats (Fig. 1), consistent with previous re- The abundance of the UT-B protein in the inner medul-
sults [5, 14]. lary base was significantly reduced in lithium-fed rats to
40% of the value in control rats (Fig. 4).
UT-A1 protein abundance
Phosphorylation of UT-A1
In the inner medullary tip, UT-A1 has two glycosy-
Inner medullary collecting duct suspensions were pre-lated forms: 97 and 117 kD [26]. The abundance of both
pared from rats fed lithium for ten days and from pair-
UT-A1 proteins was significantly reduced in the inner
fed control rats. Rats fed lithium for 10 days had a serum
medullary tip of lithium-treated rats to 50% of the value lithium level of 0.5  0.1 mmol/L (Table 2). They had sig-
in control rats (Fig. 2). In the inner medullary base, only nificantly increased urine volume and decreased urine os-
the 97 kD form was detected [27] and the abundance of molality compared to those of pair-fed control rats. Treat-
this UT-A1 protein was significantly reduced in lithium- ing IMCD suspensions from control rats with 100 pmol/L
fed rats to 25% of the value in control rats (Fig. 3). vasopressin resulted in a marked increase in UT-A1
Similar results were obtained from rats fed lithium for phosphorylation (Fig. 5), similar to our previous finding
[19]. In contrast, there was no increase in UT-A1 phos-ten days (data not shown).
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Fig. 3. UT-A1 urea transporter protein abun-
dance in kidney inner medullary (IM) base
from control rats and rats fed LiCl for 25 days.
(A) Representative Western blot showing
UT-A1 protein bands in IM base from control
(C) and LiCl-fed (Li) rats. Each lane repre-
sents a sample from a separate rat. (B) Densi-
tometric summary of the 97 kD band on the
gels. There was a significant decrease in the
density of the 97 kD band in LiCl-fed rats
compared to control rats. Data are mean 
SE, N  8 rats/group; *P  0.05.
Fig. 5. Phosphorylation of UT-A1 in inner medullary collecting duct
(IMCD) suspensions from control rats (A) and rats fed LiCl for 10
days (B) in response to 100 pmol/L vasopressin. A representative auto-
radiogram is presented showing that 100 pmol/L vasopressin increases
32PO4-incorporation into the 117 and 97 kD UT-A1 proteins in IMCDs
from control rats but not from rats fed lithium. This result was repeatedFig. 4. UT-B urea transporter protein abundance in kidney inner med-
in two additional pairs of lithium-fed rats (data not shown).ullary (IM) base from control rats and rats fed LiCl for 25 days. (A)
Representative Western blot showing UT-B protein bands in IM base
from control (C) and LiCl-fed (Li) rats. Each lane represents a sample
from a separate rat. (B) Densitometric summary of the 40 to 50 kD
band on the gels. There was a significant decrease in the density of the phorylation in IMCD suspensions from lithium-fed rats
40 to 50 kD band in LiCl-fed rats compared to control rats. Data are that were treated with 100 pmol/L vasopressin (Fig. 5).mean  SE, N  6 rats/group; *P  0.05.
When IMCD suspensions were treated with a 1000-fold
greater concentration of vasopressin (100 nmol/L), UT-
A1 phosphorylation was increased similarly in IMCDs
Table 2. In vivo parameters following 10 days of lithium administration from control and lithium-fed rats (Fig. 6).
Parameter Control rats Lithium-treated rats Liver
Initial body weight g 24810 25611
The liver expresses 49 and 36 kD UT-A bands; theFinal body weight g 26011 2587
Serum lithium mmol/L — 0.50.1a 49 kD band is a membrane protein [22]. The abundance
Urine lithium mmol/L — 61a of the 49 kD UT-A protein was significantly increased
24-hour urine volume mL 162 8610a
by 40% in livers from rats fed lithium for 10 days, com-Urine osmolality mOsm/kg H2O 1200190 26030a
pared to control rats (Fig. 7). We obtained similar resultsData are mean  SE, N  9 rats/group.
a Significantly different from pair-fed control rats at P  0.05 from rats fed lithium for 25 days (data not shown).
Klein et al: Urea transporter regulation in LiCl-fed rats 999
Fig. 6. Phosphorylation of UT-A1 in IMCD suspen-
sions from control rats (B) and rats fed LiCl for 10
days (A) in response to 100 nmol/L vasopressin. The
top panels show representative autoradiograms show-
ing that 100 nmol/L vasopressin increases 32PO4-
incorporation into the 117 and 97 kD UT-A1 proteins
in IMCDs from rats fed lithium, similar to the re-
sponse in IMCDs from control rats. Each lane repre-
sents a sample from a separate rat. Bottom panel A
is a densitometric summary of the 117 and 97 kD
bands on the autoradiograms. There was a significant
increase in the 32PO4-incorporation of the 117 and
97 kD band in LiCl-fed rats. Data are mean  SE,
N  3 lithium-fed rats/group; *P  0.05.
Fig. 7. UT-A urea transporter protein abun-
dance in liver from control rats and rats fed
LiCl for 10 days. (A) Representative Western
blot showing UT-A protein bands in liver from
control (C) and LiCl-fed (Li) rats. Each lane
represents a sample from a separate rat. (B)
Densitometric summary of the 49 kD band on
the gels. There was a significant increase in
the density of the 49 kD band in LiCl-fed rats
compared to control rats. Data are mean 
SE, N  6 rats/group; *P  0.05.
DISCUSSION These previous studies show that UT-A1 protein abun-
dance increases during in vivo conditions associated withOur major finding is that the protein abundance of
nephrogenic diabetes insipidus and a reduced plasmaUT-A1, located in the IMCD [20], and UT-B, located
vasopressin level. Thus, chronic lithium administration isin descending vasa recta [23], are significantly reduced
the first rat model of nephrogenic diabetes insipidus inin the renal inner medulla of rats fed lithium for 10 or
which UT-A1 protein abundance decreases.25 days, while UT-A protein abundance is increased in
Interstitial urea concentration is reduced in rats fed lith-liver. The reduction in UT-A1 protein contrasts with
ium [11], but it is also reduced during water diuresis orresults of previous studies of rats that had a urine concen-
feeding a low protein diet [34, 35] despite UT-A1 proteintrating defect (due to a low-protein diet, hypercalcemia,
abundance increasing in these conditions [32]. Thus, in-water diuresis, or furosemide diuresis) since UT-A1 pro-
terstitial urea concentration does not appear to dependtein abundance (and facilitated urea permeability) are
increased in each of these conditions [20, 21, 27–33]. solely on UT-A1 protein abundance. The reduced sensi-
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tivity of UT-A1 to phosphorylation by a physiologic va- of the UT-A1 proteins in IMCD suspensions [19]. The
sopressin concentration (Fig. 5) and/or the decreases in vasopressin dose-response for stimulation of UT-A1
UT-A1 and UT-B proteins (Figs. 2–4), may be the expla- phosphorylation matches that for stimulation of cyclic
nation for the decrease in inner medullary interstitial AMP production in IMCDs [18, 19]. In lithium-treated
urea concentration in lithium-treated rats [11]. rats, several groups have reported that cyclic AMP pro-
Why does UT-A1 decrease in lithium-treated rats and duction in response to vasopressin in IMCDs is blunted:
not in other models of nephrogenic diabetes insipidus? it is reduced following lower concentrations of vasopres-
One possibility is that plasma vasopressin levels and sin but not following higher vasopressin concentrations
vasopressin mRNA abundance in the paraventricular [7–13, 42, 43]. Consistent with these studies, IMCD sus-
and supraoptic nuclei of the brain are increased in lith- pensions from lithium-treated rats showed no increase
ium-treated rats [6], while vasopressin levels are reduced in UT-A1 phosphorylation following exposure to a phys-
during water diuresis. We have shown that administering iologic concentration of vasopressin, but did respond to
vasopressin to Brattleboro rats decreases UT-A1 protein a pharmacologic concentration of vasopressin. The re-
abundance [32]. Another possibility is that lithium ad- sponse to the high concentration of vasopressin was simi-
ministration has been shown to increase adrenocorti- lar to the response measured in IMCD suspensions from
cotropic hormone (ACTH) secretion and glucocorticoid
control rats [19].levels in rats [36–39], and we also found that UT-A1
protein abundance is decreased in adrenalectomized rats Aquaporin-2
that are given a stress dose of dexamethasone [20]. These
Chronic lithium administration markedly reduces AQP2findings suggest the possibility that chronic lithium ad-
protein abundance in the inner medulla of rats [1, 5]. Weministration may decrease UT-A1 protein abundance
used a similar model of chronic lithium administration [5,via an increase in vasopressin and/or glucocorticoids.
6, 11, 14], and consistent with these earlier studies, serumFuture studies are needed to address these questions.
lithium levels are at the lower end of the therapeutic range
UT-B for human patients; the rats had significantly reduced
urine osmolality and were polyuric. Thus, the physiologicIn humans, the Kidd antigen is a minor blood group
characteristics of the rats in our study are comparableand is the UT-B protein [reviewed in 15]; it is expressed
in erythrocytes and vasa recta [23]. We previously showed to those in previous studies.
that individuals lacking the Kidd antigen [Jk(ab) or As in earlier studies, we found that AQP2 protein
Jk null] are unable to concentrate their urine above 800 abundance was reduced in the inner medulla [1, 5]. We
mOsm/kg H2O, presumably by decreasing the efficiency extended this finding by showing that the reduction in
of counter-current exchange [reviewed in 15]. Thus, the AQP2 protein occurs in both the base and the tip regions
decrease in UT-B protein (Fig. 4) may contribute to of the inner medulla, corresponding to the location of
the concentrating defect by a similar mechanism in the the initial and terminal IMCD, respectively. Since the
lithium-treated rats. AQP2 promoter contains a cAMP response element [44],
it is possible that the decrease in AQP2 protein couldLiver
result from the diminished cyclic AMP response to low
In contrast to the decrease in UT-A1 and UT-B pro- concentrations of vasopressin [7–13].
teins in the kidney medulla, the 49 kD UT-A protein in
liver was increased in the lithium-treated rats (Fig. 7),
suggesting that the regulation of this liver UT-A protein CONCLUSION
differs from the regulation of the kidney UT-A1 protein. The present study shows that chronic lithium adminis-
The rat UT-A gene has two promoter elements and tration (1) decreases UT-A1 protein abundance in the
seven cDNA isoforms have been cloned to date [40, 41]. inner medullary tip and base; (2) decreases AQP2 pro-
It is tempting to speculate that this genetic complexity
tein abundance in the inner medullary tip and base; andcould potentially permit differential regulation of the
(3) blunts the phosphorylation of UT-A1 in response toliver and kidney urea transporters. Another factor that
a physiologic concentration of vasopressin but not tomay contribute to the difference between kidney inner
a pharmacologic concentration. Thus, chronic lithiummedulla and liver is that the lithium concentration in
administration is the first rat model of nephrogenic dia-vasa recta blood may be higher than in systemic (or
betes insipidus in which UT-A1 protein abundance de-portal) blood due to counter-current multiplication
creases, rather than increases [20, 21, 27–33]. We con-and/or counter-current exchange in the medulla.
clude that the decreases in UT-A1 and UT-B protein
UT-A1 phosphorylation abundance and/or the decreased sensitivity of UT-A1 to
phosphorylation by vasopressin contribute to the reduc-Our recent study showed that vasopressin, acting
through protein kinase A, increases the phosphorylation tion in urine concentrating ability in lithium-treated rats.
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